Sale of Securities

Roivant Sciences Ltd. Filed 2025-12-29 Acc 0001950047-25-010705

Documents 1

2025-12-29 144 Sale of Securities
2025-12-29 144 Sale of Securities
2025-12-29 144 Sale of Securities
2025-12-29 4 President and Vant Chair acquired 175,380 shares (grant or award)
2025-12-29 4 CFO sold 406,731 shares at an average $22.43 ($9,122,307)
2025-12-29 4 President & Immunovant CEO sold 275,000 shares at an average $22.47 ($6,179,750)
2025-12-23 144 Sale of Securities

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

Loading xsl144X01/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…